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Abstract 
Objective: To determine the frequency of HCV and HBV 
in patients referred for screening at Zulfiqar Ali Bhutto 
Medical University, PIMS, Islamabad. 
Material and Methods: This retrospective study was 
conducted at the Pathology Department of Shaheed Zulfiqar 
Ali Bhutto Medical University, PIMS, Islamabad over 
duration of 3 months (from 1
st
 January, 2014 to 31
st
 
December 2014). The data was analyzed with, Microsoft 
Excel 2010. 
Results: Total of 28319 (17040 + 11279) serum samples 
were tested by ELISA for HCV antibody and HBV antigen 
respectively. Among the positive samples, 3427 (12.1%) 
samples were found positive for HCV antibodies, while 843 
(7.5%) were positive for HBV antigen. However, the 
number of samples testing positive for both HBV and HCV 
out of the total sample size of 28319 were 143 (0.5%). 
Conclusion: HCV has a higher seropositivity, being more 
prevalent in females, effecting mostly patients between the 
ages of 36 years to 46 years compared to HBV that has a 
lower seropositivity, effecting mostly females with highest 
number of samples recorded between the ages of 25 years to 
35 years. However, it should be kept in mind that these are 
patients and not healthy donors/ or population. 
Key words: Co- infection, Enzyme-Linked Immunosorbent 
Assay, Hepatitis B, Hepatitis C, Liver damage.   
Introduction 
World Health Organization (WHO) estimates that there are 
350 million people with chronic hepatitis B (HBV) infection 
and 170 million people with chronic hepatitis C (HCV) 
infection worldwide.
1 
Hepatitis B is estimated to result in 
563 000 deaths and hepatitis C in 366000 deaths 
annually. Pakistan is amongst the worst afflicted nations. 
Pakistan carries one of the world’s highest burden of chronic 
hepatitis and mortality due to liver failure and hepatocellular 
carcinomas.
2 
In a recent note WHO has rated Pakistan as a 
2
nd
 country having high rate of chronic hepatic infection in 
the world. According to a national survey conducted in 
Pakistan on the general population by Pakistan Medical 
Research Council in 2007-2008, the seroprevalence of anti 
HCV and HbsAg was 4.8% and 2.5%, respectively 
suggesting a total chronic carrier population of hepatitis B 
and C of about 13 million.
1,3
 
HBV and HCV are blood borne hepatotropic viruses leading 
to significant morbidity and mortality worldwide. HBV is a 
member of Hepadnaviridae family, harboring a DNA 
genome, while HCV is RNA virus that belongs to 
Flaviviridae family. HCV infection results in number of 
complications including cirrhosis and hepatocellular 
carcinoma.  HCV-related end stage liver disease is one of 
the leading reasons for liver transplantation today.
2 
Hepatitis 
C virus (HCV) is the major cause of parenterally transmitted 
non-A non-B hepatitis. About 15% of patients recover or 
have a benign outcome while the rest develop a chronic 
infectious state, out of these 20% patients will develop liver 
cirrhosis over a period of 10-20 years and will succumb their 
life to it in the absence of liver transplantation. One to five 
percent develop hepatocellular carcinoma. Even in the 
asymptomatic carrier, a compromise in the quality of life has 
been reported.
4 
Hepatitis B is also potentially life-threatening liver infection. 
Both, the whole, intact virion as well as the incomplete virus 
particles, consist entirely of HbsAg and are produced during 
replication of HBV as the infected hepatocytes reproduce. It 
can cause chronic liver disease and chronic infection and 
puts the people at high risk of death from cirrhosis of the 
liver and liver cancer. About 90-95% of the patients 
contracting hepatitis B virus recover on their own due to 
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their strong immune system, in 0.5% cases hepatitis ensues 
to a fulminant form and death of the patient occurs while the 
remaining patients tend to have a persistent infection, or 
become asymptomatic carriers, developing chronic 
persistent hepatitis, out of these 1-2% patients clear the virus 
while the remaining eventually develop chronic, active 
hepatitis  leading to cirrhosis and hepatocellular carcinoma.
4
 
Intra-familial spread, horizontal transmission of hepatitis B 
is quite high. Hepatitis B is an important occupational 
hazard for health workers. 
4 
HCV infection is diagnosed through detection of HCV 
antibodies (anti HCV) that is produced when a person is 
infected with HCV. Anti-HCV can be detected with a less 
sensitive method i.e. Immuno chromatography (ICT) and a 
more sensitive and specific test Enzyme Linked 
Immunosorbant Assay (ELISA). ELISA is used as the most 
reliable screening test. Viral genome is detected in blood 
through PCR. During window period of one and half months 
Anti-HCV test may be negative.
 
Due to the presence of HCV and HBV associated liver 
diseases and the development of effective treatments, the 
diagnosis of the two infections is a growing medical need.
5
 
Purpose of this study is to estimate the frequency of HCV 
and HBV at Shaheed Zulfiqar Ali Bhutto Medical 
University, PIMS Islamabad. PIMS being a tertiary care 
hospital receives multiple referred cases from areas adjacent 
to Islamabad. These figures and findings will be helpful for 
health policy makers, blood banks and national prevention 
and surveillance program for further research and 
investigations. 
Materials and Methods 
This cross sectional study was conducted at the Pathology 
department of Shaheed Zulfiqar Ali Bhutto Medical 
University, Pakistan Institute of Medical Sciences (PIMS), 
Islamabad over a period one year (from 1
st
 January, 2014 to 
31
st
 December, 2014). All the samples received in 
Microbiology lab for screening of Hepatitis B and c were 
included in the study. These samples were collected under 
standard procedures. The samples were collected in gel 
tubes and HBsAg and anti-HCV were detected by 3
rd
 
Generation and 4
th
 Generation kits respectively (Bio kit, 
Spain) on semi-automated ELISA system BEST 2000. (Bio. 
kit, Spain) Data variables included age, gender, and co 
infection of HCV and HBV. Duplicate and follow-up 
samples were excluded. The data was analyzed with, 
Microsoft Excel 2010. 
Results 
A total of 28,319 (17040 + 11279) serum samples were 
tested by ELISA for HCV antibody and HBV antigens, 
respectively. Among the positive samples, 3427 (12.1%) 
samples were found positive for HCV antibodies, while 843 
(7.5%) were positive for HBV antigen. The number of 
samples positive for both HBV and HCV were 143 (0.5%). 
Out of the total HCV positive samples, 1742 (50.8%) were 
of females while 1685 (49.0%) were of males, male to 
female ratio being 0.9:1.0. And out of the total HBV 
positive samples, 424 (51%) samples were of females while 
419 (49%) were of males, male to female ratio being 
0.9:1.0. However, out of the total number of samples that 
showed co infection, 58 samples were of females while 87 
samples were of male. Male to female ratio being 1.5:1. Age 
group yielding the highest number of positive HBV Ag 
results ranged from 25 years to 35 years while the lowest 
positive age group was below 14 years of age. (Table 2, and 
Figure 1). 
 
Table 1: Gender distribution of patients testing positive for 
HCV (n=3247), HBV (n=843), and co infection (n=143) 
Gender  Males (n%) Females (n%) 
HCV positive 1685 (49.0%)  1742 (51.0%) 
HBV Ag positive 419 (49%) 424 (51%) 
Co infection  87 (60%) 58 (40%) 
 
Table 2: Age distribution of positive cases (n=4270) 
Age Group 
 (in years)        
HCV positive 
(n=3427) 
HBV positive 
(843) 
< 14 44 (1.3%) 14(1.7%) 
14 to 24  266(7.7%) 192(22.8%) 
25 - 35 880(25.6%) 245(29.1%) 
36 - 46 978(28.5%) 189(22.4%) 
47 - 57 687(20.0%) 119(14.1%) 
58 - 68  403(11.8%) 78(9.3%) 
> 69 and above 155(4.5%) 24(2.8%) 
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Figure 1: Age distribution of patients tested for HCV 
(n=3247) and HBV infections (n=843). 
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Table 3: Frequency of anti HCV on different population 
sample 
Author’s name  Place Population Percentage 
Nafees et al 
8 
Faislabad Visiting 
Hospital 
17.77% 
Tareen et al
9 
Quetta Blood Donors 20.8% 
Ali et al 
10 
Mansehra General 10.3% 
Ali et al 
10 
Shamdhra General 11% 
Khattak et al
11 
D.I.Khan Visiting OPD 6.54% 
 
Discussion 
Hepatitis B and C are a worldwide health hazard. Multiple 
studies have been conducted for estimation of 
seroprevalence of HBsAg and HCV antibodies targeting 
different populations of Pakistan.
 
Results of the present 
study show the high rates of seroprevalence of HCV & HBV 
amongst the hospital based population of Islamabad. 
According to this study, the percentage of HCV antibodies is 
much higher than the HBsAg. Abdul Basit et al 2014 
reported results consistent with our study, with lower 
prevalence of HBsAg than HCV antibodies.
6 
Out of the total 
serum samples tested 12.1% were positive for HCV 
antibody, 7.5% were positive for HBV antigen while 0.50% 
patients tested positive for both, HBV and HCV. 
Atif G. et al in 2009
 
reported 10.4% prevalence of HCV 
antibodies and Basit A. et al in 2014
 
reported 0.7% co 
infection amongst the patients visiting PIMS, Islamabad.
6,7
 
These results are similar to the present study. According to 
different studies conducted throughout Pakistan, on different 
population groups the prevalence of anti HCV is between 
6.54% to 17.7% as evident from the table 3 below. 
Unlike our study where samples were either from in patient 
or out-patient departments of PIMS, having a relatively 
higher number of patients with deranged liver profile tests, 
transplant patients, patients on hemodialysis, HIV patients 
or higher number of drug abusers, hence, showing a 
relatively higher prevalence percentage compared to the 
subjects employed from the general population that 
participated in most of the studies mentioned in table above. 
There has been a lot of variation in the seroprevalence of 
anti HCV worldwide ranging 0.47% in Nepal
12
 to 13.9% in 
Egypt
13 
amongst general population. 
The prevalence of HCV as recorded in this study was higher 
in females, 51.0% compared to males, 49.0%. High rate of 
HCV seropositivity in our study is due to type of samples 
(i.e. from patients and not the general population) and is 
thought to be chiefly due to exposure during major and /or 
minor surgical procedures due to usage of improperly 
sterilized surgical equipment.
14
  
The highest HCV seropositivity recorded amongst the 
patients between the ages 36 - 46yrs. (28.5%) and the lowest 
being amongst patients below the age of 14 years (1.3%). 
Unsafe injecting practices, intravenous drug abuse, high 
number of dental procedures, endoscopy, major and minor 
operation and unsafe sexual practices, all have a 
contributory effect on the overall seroprevalence of HCV 
especially in ages between 36 years to 46 years.   
The global prevalence of HBV infection varies widely; and 
its endemicity ranges from high (≥8%) to intermediate (2-
7%) and low (<2%).
15
 According to different studies, the 
seroprevalence HbsAg (by ELISA) of patients visiting 
different health facilities within Islamabad is between 3.9% 
to 15%
6,16. 
This is compliant with the result of this study. 
According to a research conducted in Liaqat University Eye 
Hospital Sindh, Pakistan on patients admitted for ocular 
treatment, 4.6% of the total tested samples were positive for 
HBV Ag. However, patients above 30 years of age were 
employed for the study, unlike this study, and the HBV Ag 
was done by the chromatographic method which is less 
sensitive than ELISA.
17 
In another study 5.7% prevalence of hepatitis B virus was 
recorded amongst the Hospital care seeking population in 
Eithopia, Africa.
15
The highest HBV seropositivity recorded 
was amongst the patients between the ages of 25 yrs.-35 yrs. 
while the lowest being observed in patients below 14 years 
of age. A study conducted in China associates HBV 
infection with the different gender, however, the reason for 
this difference in result is unclear. It is speculated to have 
been due to differences in the immune response to the HBV 
infection.
18 
The incidence of HBV infection is also related to 
different occupations, risky social activities, personal history 
of vaccination, and age in adults.
18 
WHO also estimates that 
in developing countries due to the use of non-sterile, reused 
syringes or needles cause 12-18 million HBV infections 
annually.
15 
It is also stated that the rate of positivity 
decreases with age due to the spontaneous seroconversion to 
the antibody against HBeAg.
18 
HBV and HCV may appear as co infections due to the same 
mode of transmission.
19 
Several studies have been 
documented that HCV and HBV co infection accelerates 
liver damage and may progresses to hepatocellular 
carcinoma. Co-infection also alters the interferon dosage 
required for treatment.
19
  HBV/HCV co infection is most 
commonly found amongst certain high risk personnel i.e. IV 
drug abusers, patients on hemodialysis, patients in 
immunocompromised states e.g. after organ transplantation 
and/ or HIV positive, and patients requiring frequent blood 
transfusions e.g. Beta thalassemia patients.
20
 However, due 
to lack of large scale population based studies conducted 
over different geographical areas and presence of silent 
HBV infection amongst many patients, the worldwide 
prevalence of HBV/HCV coinfection is not known.
20 
A 
study conducted on adult, females in Karachi estimated the 
co infection rate by both these viruses to be 1.4%.
21 
However, according to another study conducted in 2011 in 
Karachi the frequency of co infection by HCV and HBV 
was 1.1%.
22 
Whereas, the prevalence of co infection in 
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national survey was 0.1%.
23 
Co-infection indicates more 
severe and difficult to treat disease with higher morbidity 
and mortality.
 
Conclusion 
High number of samples were tested positive for HCV and 
HBV at PIMS. There is thus great need for improved health 
policies and to increase awareness against HCV and HBV 
amongst the general population and high risk population to 
prevent people from contracting the virus and/or early 
detection of the disease. 
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